Selectis Health, Inc. (GBCS)
OTCMKTS · Delayed Price · Currency is USD
4.400
0.00 (0.00%)
At close: Apr 17, 2026

Selectis Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Rental Revenue
-0.320.630.590.63
Property Management Fees
----0.22
Other Revenue
41.4439.1736.1540.0128.44
41.4439.4936.7840.629.29
Revenue Growth (YoY
4.93%7.36%-9.40%38.63%39.94%
Property Expenses
31.7630.3631.3829.8621.47
Selling, General & Administrative
8.899.259.977.875.91
Depreciation & Amortization
1.471.571.671.791.73
Total Operating Expenses
43.0142.2245.7440.8930.02
Operating Income
-1.56-2.73-8.96-0.29-0.73
Interest Expense
-1.73-2.05-2.17-2.23-2.5
Other Non-Operating Income
1.540.120.130.130.17
EBT Excluding Unusual Items
-1.75-4.66-11.01-2.39-3.06
Gain (Loss) on Sale of Assets
-2.11---
Other Unusual Items
0.730.127.04-0.010.82
Pretax Income
-1.01-2.42-3.97-2.4-2.24
Income Tax Expense
0----
Earnings From Continuing Operations
-1.02-2.42-3.97-2.4-2.24
Minority Interest in Earnings
-----0.01
Net Income
-1.02-2.42-3.97-2.4-2.25
Preferred Dividends & Other Adjustments
0.040.020.030.030.03
Net Income to Common
-1.05-2.45-4-2.43-2.28
Basic Shares Outstanding
33333
Diluted Shares Outstanding
33333
Shares Change (YoY)
-0.41%0.01%10.33%-10.91%
EPS (Basic)
-0.34-0.80-1.31-0.79-0.82
EPS (Diluted)
-0.34-0.80-1.31-0.79-0.82
Operating Margin
-3.78%-6.91%-24.36%-0.71%-2.49%
Profit Margin
-2.54%-6.19%-10.88%-5.97%-7.79%
EBITDA
-0.09-1.16-7.291.511
EBITDA Margin
-0.22%-2.94%-19.83%3.71%3.43%
D&A For Ebitda
1.471.571.671.791.73
EBIT
-1.56-2.73-8.96-0.29-0.73
EBIT Margin
-3.78%-6.91%-24.36%-0.71%-2.49%
Revenue as Reported
41.4439.4936.7840.629.29
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.